Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000352260

Medchemexpress LLC DSR-141562 | 2007975-22-4 | 100.0% | 414.42 | 50 MG
SDP

Catalog No. 5000352260
Encompass_Preferred

DSR-141562 is a novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor. It shows preferential selectivity for human PDE1B with an IC50 of 43.9 nM, and IC50 values for human PDE1A and 1C are 97.6 and 431.8 nM, respectively. It can be used for the study of positive symptoms, negative symptoms, and cognitive impairments associated with schizophrenia.

  • Novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor.
  • Shows preferential selectivity for human PDE1B.
  • Applicable for studying positive symptoms, negative symptoms, and cognitive impairments related to schizophrenia.

Catalog No. 50-003-52260 Supplier Medchemexpress LLC Supplier No. HY13656950MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DSR-141562 is a novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor. It shows preferential selectivity for human PDE1B with an IC50 of 43.9 nM, and IC50 values for human PDE1A and 1C are 97.6 and 431.8 nM, respectively. It can be used for the study of positive symptoms, negative symptoms, and cognitive impairments associated with schizophrenia.

  • Novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor.
  • Shows preferential selectivity for human PDE1B.
  • Applicable for studying positive symptoms, negative symptoms, and cognitive impairments related to schizophrenia.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.